Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm... Show more
Agilent Technologies, Inc. (A) follows a quarterly dividend policy with payments of $0.255 per share. This results in an annualized dividend of $1.02 and a yield near 0.90%. The company is viewed as a dividend growth stock rather than a high-yield name, given its modest yield and focus on consistent increases. Payments occur four times per year, with recent ex-dividend dates including March 31, 2026, and a payable date of April 22, 2026. The approach emphasizes long-term shareholder returns through measured growth rather than aggressive income generation.
Agilent has maintained a track record of steady dividend increases since resuming payments after its 1999 spin-off. Annualized payouts have risen from under $0.50 per share in earlier years to the current $1.02 level. Growth has averaged in the mid-single digits annually in recent periods, supported by rising earnings. The company has avoided dividend cuts during economic cycles, reflecting a conservative approach to shareholder distributions. This pattern aligns with a long-term strategy of rewarding investors through gradual enhancements rather than large one-time boosts.
The dividend appears highly sustainable, backed by a payout ratio of approximately 22%. This low ratio indicates that earnings cover the dividend more than four times over. Free cash flow generation remains robust, providing ample coverage for the current payout while leaving room for reinvestment and potential future increases. Debt levels are manageable, and overall financial stability supports continued payments without strain. Analysts note that the conservative policy positions Agilent well for maintaining or growing the dividend even in challenging environments.
Within the life sciences and healthcare equipment sector, Agilent’s yield of roughly 0.90% sits below several peers that offer yields in the 1.5% to 3% range. Companies with larger market positions in diagnostics or broader healthcare often provide higher current income. However, Agilent’s lower payout ratio and growth trajectory differentiate it from higher-yielding names that may face greater pressure to maintain distributions. Investors comparing options will note that Agilent prioritizes balance sheet strength and earnings growth over immediate yield.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.
Agilent Technologies (A) may appeal to dividend growth investors who prioritize long-term compounding over high current income. Its low payout ratio and consistent increases make it suitable for conservative, long-term holders focused on capital appreciation alongside modest distributions. Income-oriented investors seeking higher yields might find better options elsewhere in the sector. The stock fits portfolios emphasizing financial stability and gradual dividend expansion rather than immediate cash flow needs. Overall, the profile suits those comfortable with a below-average yield in exchange for sustainability and growth potential.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of measurement and monitoring instruments
Industry MedicalSpecialties